Emapalumab (anti-IFNγ)
Product Specifications
CAS Number
1709815-23-5
Synonyms
Gamifant
Target
IFN
Applications
Immunology & Inflammation
Additionnal Information
Emapalumab (anti-IFNγ), a monoclonal antibody directed against IFNγ, is the first global approval for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940257-500 1x 500 µL
Cytokeratin, HMW (AE-3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472652-500 1x 500 µL
B7-H4 (Immuno-Inhibitory Protein) (B7H4/2652R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB0158-500 1x 500 µL
Cytokeratin 17 (E3), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742298-500 1x 500 µL
Cytokeratin 8/18 (rKRT8.18/1346), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB0257-100 1x 100 µL
Cytokeratin, HMW (AE-3), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details